What 135 ADHD Brains Have in Common Genetically
Posted on
By katie gironda
If you have ADHD and you have tried everything — better sleep, cleaner eating, therapy, even medication — and your brain still won't cooperate, your genes may be telling you exactly why.

We run nutrigenomic reports for hundreds of clients. When we pulled the data on every client who mentioned ADHD, a striking pattern emerged across 135 people. The same genetic variants kept appearing, over and over, across completely different individuals.
These are clustered biological bottlenecks. The specific places in your biochemistry where your ADHD brain is most likely running low on what it needs.
Here is what the data shows, and what it means for your brain, your supplements, and your daily function.
COMT is the enzyme responsible for breaking down dopamine, norepinephrine, and adrenaline after they have done their job. In 133 out of 135 ADHD clients, this gene came up.
A slower COMT means these neurotransmitters linger longer than they should. For some people that looks like hyperfocus, intensity, or an inability to downshift after stress. For others it is anxiety, emotional overreactivity, and a brain that cannot turn off.
MTHFR converts dietary folate into its active form, which feeds into the methylation cycle. The methylation cycle governs neurotransmitter production, hormone clearance, DNA repair, and stress recovery.
In ADHD brains, impaired methylation often shows up as low serotonin and dopamine production, elevated homocysteine, and difficulty with emotional regulation.
SOD2 is a mitochondrial antioxidant enzyme that neutralizes superoxide radicals produced during energy metabolism. When SOD2 efficiency is reduced, oxidative stress accumulates inside the mitochondria.
This is one of the most underrecognized patterns in ADHD. Mitochondrial oxidative stress impairs neurotransmitter synthesis, disrupts focus, and drives the physical fatigue many ADHD people experience alongside cognitive symptoms.
GSTP1 is a phase II detox enzyme that conjugates toxins to glutathione for removal. Glutathione is the master antioxidant of the brain. When GSTP1 is reduced, the brain's ability to clear oxidative byproducts, environmental toxins, and neuroinflammatory compounds slows.
Neuroinflammation is increasingly recognized as a driver of attention dysregulation, sensory sensitivity, and emotional dysregulation. Many clients with GSTP1 variants also show sensitivity to mold, fragrances, and food chemicals.
FADS2 encodes the enzyme that converts short-chain fatty acids from food into the long-chain DHA and EPA that make up brain cell membranes. DHA is the primary structural fat in neurons. Low DHA in brain membranes reduces membrane fluidity, impairs signal transmission, and has been directly associated with attention difficulties and impulsive behavior.
MTRR regenerates active B12 after it has been used in the methylation cycle. Without adequate MTRR function, B12 gets trapped in an inactive form and cannot re-enter the cycle. B12 is required for myelin production, neurotransmitter synthesis, and homocysteine clearance.
MAOA breaks down serotonin, dopamine, and norepinephrine in the synaptic space. Combined with a slow COMT, slower MAOA activity means neurotransmitters accumulate in ways that dysregulate mood, sleep, and impulse control.
GAD1 converts the excitatory neurotransmitter glutamate into GABA, the brain's primary inhibitory signal. GABA is what allows the brain to slow down, filter out irrelevant stimuli, and maintain focus without tipping into overwhelm.
Low GAD1 efficiency shifts the excitatory-inhibitory balance toward excitation. This shows up as difficulty filtering sensory input, emotional dysregulation, racing thoughts, and the paradoxical exhaustion that comes from a brain that cannot quiet itself.
SLC30A8 regulates zinc transport. Zinc is required for dopamine metabolism, NMDA receptor regulation, and hippocampal function, areas directly tied to attention and memory. Low zinc availability impairs dopamine synthesis, reduces dopamine receptor sensitivity, and compromises gut-brain axis integrity.
HFE regulates iron absorption and metabolism. Iron is required for dopamine synthesis and myelin sheath function. Iron deficiency, even subclinical, is associated with reduced dopamine receptor binding and increased ADHD symptom severity.
These variants do not operate in isolation. They cluster into a few core physiological bottlenecks.
Methylation and neurotransmitter synthesis: MTHFR, MTRR, and MAOA all sit inside the same one-carbon metabolism and neurotransmitter production system. When methylation slows, B12 recycles poorly, neurotransmitter production drops, and dopamine clearance through COMT backs up simultaneously.
Oxidative stress and brain inflammation: SOD2, GSTP1, and the downstream antioxidant system govern whether the brain can clear its own metabolic waste. When oxidative stress accumulates, COMT and MAOA enzyme function degrades further, creating a self-reinforcing cycle.
Membrane quality and signal speed: FADS2 sits outside the methylation loop but directly determines whether the physical structure of your neurons can transmit signals efficiently. No amount of neurotransmitter optimization compensates for poor membrane fluidity.
Inhibitory tone: GAD1 controls whether the brain can use its own braking system. Without enough GABA production, the brain runs chronically over-stimulated regardless of what dopamine levels look like.
Mineral cofactors: Zinc, iron, and magnesium are required across nearly every variant on this list. They are limiting factors that determine whether the enzymes above can function at all.
ADHD is not a character flaw or a deficit of willpower. For the vast majority of people who carry these variants, the brain's regulatory chemistry is operating under nutritional constraints that no behavioral strategy alone can fully compensate for.
That does not mean everyone with these variants needs the same protocol. COMT slow metabolizers respond differently to methyl donors than fast metabolizers. FADS2 variants need preformed DHA. MTHFR A1298C behaves differently than C677T. The sequencing of support matters, and what helps one person can make another feel worse.
This is why nutrigenomic data paired with clinical context is more useful than a generic supplement stack.
Across 135 people who came to us reporting ADHD, the biology points to the same places: methylation, oxidative stress, membrane integrity, inhibitory neurotransmission, and the minerals that hold all of it together.
Katie is the founder of Molecular Health Co. and the Institute of Integrative Biomedicine, specializing in orthomolecular medicine and nutrigenomics. This post is for educational purposes and does not constitute medical advice. Genetic data should be interpreted in the context of a full clinical picture.